Development and internal validation of preoperative transition zone prostate cancer nomogram.

Standard

Development and internal validation of preoperative transition zone prostate cancer nomogram. / Steuber, Thomas; Chun, Felix K-H; Erbersdobler, Andreas; Briganti, Alberto; Haese, Alexander; Graefen, Markus; Schlomm, Thorsten; Valiquette, Luc; Huland, Hartwig; Karakiewicz, Pierre I.

In: UROLOGY, Vol. 68, No. 6, 6, 2006, p. 1295-1300.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Steuber, T, Chun, FK-H, Erbersdobler, A, Briganti, A, Haese, A, Graefen, M, Schlomm, T, Valiquette, L, Huland, H & Karakiewicz, PI 2006, 'Development and internal validation of preoperative transition zone prostate cancer nomogram.', UROLOGY, vol. 68, no. 6, 6, pp. 1295-1300. <http://www.ncbi.nlm.nih.gov/pubmed/17141836?dopt=Citation>

APA

Steuber, T., Chun, F. K-H., Erbersdobler, A., Briganti, A., Haese, A., Graefen, M., Schlomm, T., Valiquette, L., Huland, H., & Karakiewicz, P. I. (2006). Development and internal validation of preoperative transition zone prostate cancer nomogram. UROLOGY, 68(6), 1295-1300. [6]. http://www.ncbi.nlm.nih.gov/pubmed/17141836?dopt=Citation

Vancouver

Steuber T, Chun FK-H, Erbersdobler A, Briganti A, Haese A, Graefen M et al. Development and internal validation of preoperative transition zone prostate cancer nomogram. UROLOGY. 2006;68(6):1295-1300. 6.

Bibtex

@article{50c7c53e389e4f4d8a13d750c33287d0,
title = "Development and internal validation of preoperative transition zone prostate cancer nomogram.",
abstract = "OBJECTIVES: Up to 20% of men may harbor a transition zone (TZ) prostate cancer (PCa) at radical prostatectomy (RP). TZ PCa may be associated with more favorable RP pathologic findings than peripheral zone (PZ) PCa. To identify these men, we developed a model capable of predicting the probability of TZ PCa at RP. METHODS: The study cohort consisted of 945 consecutive men treated with RP, with clinical stage, prostate-specific antigen (PSA) level, and detailed biopsy and RP pathology data available. The preoperative variables were used as predictors in the multivariate logistic regression models to predict the rate of TZ PCa at RP. PCa was defined as a TZ tumor when more than 50% of the planimetrically measured tumor volume was situated within the TZ. Regression coefficients were used to develop nomograms, which were subjected to 200 bootstrap resamples to reduce overfit bias. RESULTS: TZ PCa at the final pathologic examination was recorded in 110 patients (11.6%). After 200 bootstraps, the most parsimonious and most accurate nomogram was 77.3% accurate in predicting the probability of TZ PCa. CONCLUSIONS: This nomogram is ideally suited to identify patients with markedly elevated, nearly metastatic serum PSA levels who harbor a TZ tumor that is highly treatable by RP.",
author = "Thomas Steuber and Chun, {Felix K-H} and Andreas Erbersdobler and Alberto Briganti and Alexander Haese and Markus Graefen and Thorsten Schlomm and Luc Valiquette and Hartwig Huland and Karakiewicz, {Pierre I}",
year = "2006",
language = "Deutsch",
volume = "68",
pages = "1295--1300",
journal = "UROLOGY",
issn = "0090-4295",
publisher = "Elsevier Inc.",
number = "6",

}

RIS

TY - JOUR

T1 - Development and internal validation of preoperative transition zone prostate cancer nomogram.

AU - Steuber, Thomas

AU - Chun, Felix K-H

AU - Erbersdobler, Andreas

AU - Briganti, Alberto

AU - Haese, Alexander

AU - Graefen, Markus

AU - Schlomm, Thorsten

AU - Valiquette, Luc

AU - Huland, Hartwig

AU - Karakiewicz, Pierre I

PY - 2006

Y1 - 2006

N2 - OBJECTIVES: Up to 20% of men may harbor a transition zone (TZ) prostate cancer (PCa) at radical prostatectomy (RP). TZ PCa may be associated with more favorable RP pathologic findings than peripheral zone (PZ) PCa. To identify these men, we developed a model capable of predicting the probability of TZ PCa at RP. METHODS: The study cohort consisted of 945 consecutive men treated with RP, with clinical stage, prostate-specific antigen (PSA) level, and detailed biopsy and RP pathology data available. The preoperative variables were used as predictors in the multivariate logistic regression models to predict the rate of TZ PCa at RP. PCa was defined as a TZ tumor when more than 50% of the planimetrically measured tumor volume was situated within the TZ. Regression coefficients were used to develop nomograms, which were subjected to 200 bootstrap resamples to reduce overfit bias. RESULTS: TZ PCa at the final pathologic examination was recorded in 110 patients (11.6%). After 200 bootstraps, the most parsimonious and most accurate nomogram was 77.3% accurate in predicting the probability of TZ PCa. CONCLUSIONS: This nomogram is ideally suited to identify patients with markedly elevated, nearly metastatic serum PSA levels who harbor a TZ tumor that is highly treatable by RP.

AB - OBJECTIVES: Up to 20% of men may harbor a transition zone (TZ) prostate cancer (PCa) at radical prostatectomy (RP). TZ PCa may be associated with more favorable RP pathologic findings than peripheral zone (PZ) PCa. To identify these men, we developed a model capable of predicting the probability of TZ PCa at RP. METHODS: The study cohort consisted of 945 consecutive men treated with RP, with clinical stage, prostate-specific antigen (PSA) level, and detailed biopsy and RP pathology data available. The preoperative variables were used as predictors in the multivariate logistic regression models to predict the rate of TZ PCa at RP. PCa was defined as a TZ tumor when more than 50% of the planimetrically measured tumor volume was situated within the TZ. Regression coefficients were used to develop nomograms, which were subjected to 200 bootstrap resamples to reduce overfit bias. RESULTS: TZ PCa at the final pathologic examination was recorded in 110 patients (11.6%). After 200 bootstraps, the most parsimonious and most accurate nomogram was 77.3% accurate in predicting the probability of TZ PCa. CONCLUSIONS: This nomogram is ideally suited to identify patients with markedly elevated, nearly metastatic serum PSA levels who harbor a TZ tumor that is highly treatable by RP.

M3 - SCORING: Zeitschriftenaufsatz

VL - 68

SP - 1295

EP - 1300

JO - UROLOGY

JF - UROLOGY

SN - 0090-4295

IS - 6

M1 - 6

ER -